Committed to Helping You Get Your Medicine
Knowing what to expect can make all the difference. We can help walk
you through each step of getting Rituxan and assist you along the
Frequently Asked Questions
About Genentech Access Solutions
What is Genentech Access Solutions?
Gennetech Access Solutions is a resource for people who take Rituxan.
We connect you to the medicine you need.
I Am Concerned About Paying for Rituxan
My co-pays for Rituxan are too high. How can you help me?
There may be options to help you get the Rituxan your doctor has
prescribed. Genentech Access Solutions can refer you to patient
Getting My Medicine
How long will it take to get my medicine?
You might not be able to get Rituxan right away. First, your doctor’s
office or specialty pharmacy will have to check to make sure your
health insurance plan covers your medicine. This is called a “benefits
investigation.” They also might have to send some more information
before your plan covers your medicine. This is called a “prior
Enrolling in Genentech Access Solutions
How do I enroll in Genentech Access Solutions?
- You fill out a form called the PAN.
- Your doctor fills out a form called the SMN. You do not have to fill out anything on this form.
- Your doctor sends both of these forms to Genentech Access Solutions.
There are 2 ways to fill out the PAN form:
- You can fill out the form online
- You can download and print it to fill out a paper copy
Why do I need to sign the PAN form?
The PAN form lets us discuss your health information with your doctor
and your health insurance plan. We can’t work with you without a
I submitted the PAN online or gave the signed PAN to my doctor. Is there anything else I need to do to enroll?
You do not need to do anything else, but your doctor does. He or she needs to submit a form called the SMN. The SMN tells us your doctor wants to treat you with Rituxan. Make sure your doctor has sent us the SMN so you get help from us.
You do not need to fill out anything on the SMN form.
My Health Plan Denied Coverage for Rituxan
My health insurance plan will not cover Rituxan. What do I do?
If your health insurance plan will not cover Rituxan, you and your
doctor’s office can file an appeal. Contact your doctor to find out if
filing an appeal is right for you.
We have resources to help you and your doctor file an appeal.
Does Genentech Access Solutions send the appeal to my health insurance plan?
We have resources to help you and your doctor file an appeal. You or
your doctor’s office has to file the appeal directly with your health
How long does an appeal take?
This depends on your health insurance plan. You should ask your plan directly about its process. Sometimes the appeals process is quick. However, it can also take several months if you have to appeal several times.
My Insurance Might Change
I am enrolled in Genentech Access Solutions and my health insurance plan has changed. What do I do next?
If your insurance changes while you’re taking Rituxan, call us. We
can help you understand your new coverage.
I no longer have a health insurance plan. What should I do?
GATCF helps people who don't have health insurance. It also helps
people who have health insurance but have trouble paying for Rituxan.
If you qualify for GATCF, you could receive your medicine for
It is your and your doctor's responsibility to complete and submit
all required paperwork to your health insurance plan. Genentech and
Biogen cannot guarantee your plan will cover any treatments.
PAN=Patient Authorization and Notice of Request
for Transmission of Health Information to Genentech Access Solutions
and Genentech® Access to Care Foundation.
SMN=Statement of Medical Necessity.
Important Safety Information & Indication
What it treats
Rheumatoid arthritis (RA): with another prescription medicine called methotrexate, to reduce the signs and symptoms of moderate to severe active RA in adults, after treatment with at least one other medicine called a tumor necrosis factor (TNF) antagonist has been used and did not work well enough.
Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis) and Microscopic Polyangiitis (MPA): in adult patients with glucocorticoids.
Pemphigus Vulgaris (PV): in adult patients with moderate to severe PV.
It is not known if Rituxan is safe and effective in children.
Important Safety Information
Rituxan can cause serious side effects that can lead to death, including:
- Infusion Reactions: Infusion reactions are very common side effects of Rituxan treatment. Serious infusion reactions can happen during or within 24 hours of the infusion. The patient’s healthcare provider should give the patient medicines before their infusion of Rituxan
- Severe Skin and Mouth Reactions: The following symptoms can occur during treatment with Rituxan: painful sores or ulcers on the skin, lips, or in the mouth; blisters; peeling skin; rash; or pustules
- Hepatitis B Virus (HBV) Reactivation: If patients have had hepatitis B or are carriers of hepatitis B virus, receiving Rituxan could cause the virus to become an active infection again. Hepatitis B reactivation may cause serious liver problems, including liver failure and death. Patients should not receive Rituxan if they have active hepatitis B liver disease. The patient’s healthcare provider will monitor the patient for hepatitis B infection during and for several months following their treatment
- Progressive Multifocal Leukoencephalopathy (PML): PML is a rare, serious brain infection caused by a virus that can happen in people who receive Rituxan. People with weakened immune systems can get PML. PML can result in death or severe disability. There is no known treatment, prevention, or cure for PML
Before receiving Rituxan, patients should tell their healthcare provider if they:
- have had a severe infusion reaction to Rituxan in the past
- currently have or have a history of other medical conditions, especially heart disease
- have had a severe infection, currently have an infection, or have a weakened immune system
- have had a recent vaccination or are scheduled to receive vaccinations
- have taken Rituxan in the past
- are pregnant or planning to become pregnant. Females who are able to become pregnant should use effective birth control (contraception) during treatment with Rituxan and for 12 months after the last dose of Rituxan
- are breastfeeding or plan to breastfeed. Patients should not breastfeed during treatment and for at least 6 months after the last dose of Rituxan
- are taking any medications, including prescription and over-the-counter medicines, vitamins, and herbal supplements
What are the possible side effects of Rituxan?
Rituxan can cause serious and life‐threatening side effects, including:
- Tumor Lysis Syndrome (TLS): TLS is caused by the fast breakdown of cancer cells. TLS can cause kidney failure and the need for dialysis treatment, or an abnormal heart rhythm
- Serious Infections: Serious infections can happen during and after treatment with Rituxan and can lead to death. Rituxan can increase the risk of getting infections and can lower the ability of the patient’s immune system to fight infections. People with serious infections should not receive Rituxan
- Heart Problems: Rituxan may cause chest pain, irregular heartbeats, and heart attack. The patient’s healthcare provider may monitor the patient during and after treatment with Rituxan if they have symptoms of heart problems or have a history of heart problems
- Kidney Problems: especially if a patient is receiving Rituxan for non–Hodgkin’s lymphoma (NHL). The patient’s doctor should do blood tests to check how well the patient’s kidneys are working
- Stomach and Serious Bowel Problems That Can Sometimes Lead to Death: Blockage or tears in the bowel can happen while receiving Rituxan with chemotherapy medicines
Most common side effects during treatment with Rituxan:
- infusion-related reactions
- infections (may include fever, chills)
- body aches
In patients with GPA or MPA, the most common side effects of Rituxan also include:
- low white and red blood cells
- muscle spasms
Other side effects with Rituxan include:
- aching joints during or within hours of receiving an infusion
- more frequent upper respiratory tract infections
These are not all of the possible side effects with Rituxan. For more information, patients should ask their doctor or pharmacist.
Report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. Report side effects to Genentech at (888) 835-2555.
For Important Side Effect Information, please see the full Prescribing Information, including Serious Side Effects, and the Medication Guide.